Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 8, 2025

December 8, 2025

Ingenovis Health Names Jason Embick the Company’s First Chief Accounting Officer

EIN Presswire

December 8, 2025

“LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Included in China’s Commercial Insurance Innovative Drug List

GlobeNewswire

December 8, 2025

The End of 'Fluff' Facials: Why Allegria Spa is Pivoting to a Results-Driven Model for Skin Health in Ohio

EIN Presswire

December 8, 2025

Imviva Biotech Presents Validating Data for CAR-T Cell Therapies CTD402 and CTA311 in Five Presentations at the 67th American Society of Hematology Annual Meeting

GlobeNewswire

December 8, 2025

Imviva Biotech Presents Clinical Breakthroughs for CTD402 in High-Mortality T-Cell and Myeloid Leukemias at the 67th American Society of Hematology Annual Meeting

GlobeNewswire

December 8, 2025

Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting

GlobeNewswire

December 8, 2025

Achieve Life Sciences Announced Granting of New Hire Inducement Awards

GlobeNewswire

December 8, 2025

Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in…

GlobeNewswire

$Autolus Therapeutics Presents Updated Clinical Data from the CARLYSLE Trial in Patients with Severe Refractory Systemic Lupus Erythematosus at the American Society of Hematology (ASH) Annual Meeting 2025$

December 8, 2025

Autolus Therapeutics Presents Updated Clinical Data from the CARLYSLE Trial in Patients with Severe Refractory Systemic Lupus Erythematosus at the American Society of Hematology (ASH) Annual Meeting 2025

GlobeNewswire

December 8, 2025

Cardiff Oncology Announces Clinical Data from Investigator-Sponsored Trial with Onvansertib in Chronic Myelomonocytic Leukemia at ASH 2025

GlobeNewswire

December 8, 2025

Protara Announces Closing of $75 Million Public Offering

GlobeNewswire

December 8, 2025

Dyne Therapeutics Announces Proposed Public Offering of Common Stock

GlobeNewswire

December 8, 2025

Fulcrum Therapeutics Announces Proposed $150.0 Million Public Offering of Common Stock

GlobeNewswire

December 8, 2025

Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants

GlobeNewswire

December 8, 2025

Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock

GlobeNewswire

December 8, 2025

Kymera Therapeutics Announces Proposed Public Offering

GlobeNewswire

December 8, 2025

Structure Therapeutics Announces Proposed $500 Million Public Offering of American Depositary Shares and Pre-Funded Warrants

GlobeNewswire

December 8, 2025

Arcutis Strengthens Board of Directors with New Appointment of Amit Munshi and Honors Retirement of Bhaskar Chaudhuri

GlobeNewswire

December 8, 2025

Tevogen Recognized on 2025 NJBIZ Power List Amid Growth and Multi-Billion-Dollar Revenue Outlook

GlobeNewswire

$Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701’s Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting$

December 8, 2025

Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701’s Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting

GlobeNewswire